Azerbaijan

Continue support for the roll-out of the electronic TB registry to achieve countrywide coverage, including the prison sector, and transfer to the new version
Update recording and reporting forms in line with the WHO case definition and recommendations of the epi-review mission for endorsement by the Ministry of Health (MoH)
Support the MoH with implementation and follow-up of the national strategy plan 2016–2020 and operationalize it to consider country need and the regional TB action plan 2016–2020
Support the MoH on implementing the Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) within activities for health system strengthening
Support the development of guidance and an implementation plan on active drug-safety monitoring
Provide further support to strengthen the laboratory network system, and introduce and implement new diagnostic methods to improve early diagnosis of multidrug and extensively drug-resistant TB (M/XDR-TB)
Coordinate upcoming country support missions from TB-REP, the regional Green Light Committee (GLC), Global Drug Facility and European Laboratory Initiative to strengthen TB and M/XDR-TB prevention and control
Continue providing support and assistance to the WHO Collaborating Centre on TB in Prisons
Monitor and follow up implementation of the countrywide expansion of programmatic management of TB and M/XDR-TB, and support self-assessment and application of infection control measures

MoH Scientific-Research Institute of Lung Diseases of Azerbaijan
Medical Department of the Ministry of Justice
Country Collaboration Mechanism
Azerbaijan Medical University
National AIDS Centre
Analytical Centre of Expertise of the MoH
Republican Centre of Hygiene and Epidemiology
Global Fund to Fight AIDS, Tuberculosis and Malaria
Global Fund Project Implementation Unit of the MoH
nongovernmental organizations: “Support to Health”, “Hayat”, “Assistance of Health Care Development”, “Azerbaijan Health Communication Association”, Azerbaijan Red Crescent Society and “People living with HIV/AIDS”
the Global Drug Facility